Controlled release of indomethacin by chitosan-polyelectrolyte complex: optimization and in vivo/in vitro evaluation

doi:10.1016/0168-3659(93)90080-O

Journal of Controlled Release

Volume 25, Issue 3, June 1993, Pages 217-225

https://doi.org/10.1016/0168-3659(93)90080-O Get rights and content

Abstract

Chitosan gel beads containing indomethacin, an acidic drug, were prepared by a polyelectrolyte complexation of sodium tripolyphosphate and chitosan. The effects of the molecular weights of chitosan hydrolysates on the release and absorption rates of indomethacin from gel beads were examined. The release rates of indomethacin decreased with increasing of molecular weight and indomethacin content. A negative correlation was observed between the molecular weight and release rate constant (r = −0.983). The release of indomethacin depended upon the dispersion of the indomethacin solid particles in the beads, as well as the porosity, tortuosity and surface area of the matrix. The plasma concentrations ofindomethacin after oral administration of chitosan gel beads to beagle dogs exhibited the sustained-release pattern. With increasing molecular weight of chitosan, the AUC and C_max were decreased, while MAT was increased. A good correlation was observed between the molecular weight of chitosan or dissolution rate constant and the MAT or AUC. The results revealed that the chitosan gel beads composed of chitosan hydrolysate, of molecular weight 25 000, might be the best for the sustained-release preparation of indomethacin. It was suggested that the absorption of other drugs could be controlled by the proper selection of chitosan hydrolysate of optimal molecular weight and predicted from in vitro dissolution tests.

References (15)

S.H. Pangburn et al.
Lysozyme degradation of partially deacetylated chitin, its films and hydrogels
Biomaterials
(1982)
T. Imai et al.
Interaction of indomethacin with low molecular weight chitosan, and improvements of some pharmaceutical properties of indomethacin by low molecular weight chitosans
Int. J. Pharm.
(1991)
Y. Kawashima et al.
Novel method for the preparation of controlled-release theophyllin granules coated with a polyelectrolyte complex of sodium polyphosphate-chitosan
J. Pharm. Sci.
(1985)
T. Higuchi
Rate of release of medicaments from ointment base containing drugs in suspension
J. Pharm. Sci.
(1961)
T. Higuchi
Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs in solid matrices
J. Pharm. Sci.
(1963)
Y. Sawayanagi et al.
Enhancement of dissolution properties of griseofulvin from ground mixtures with chitin or chitosan
Chem. Pharm. Bull.
(1982)
Y. Sawayanagi et al.
Enhancement of dissolution properties of prednisolone from ground mixtures with chitin or chitosan
Chem. Pharm. Bull.
(1983)

There are more references available in the full text version of this article.

Cited by (173)

Chitosan-based hemostatic sponges as new generation hemostatic materials for uncontrolled bleeding emergency: Modification, composition, and applications
2023, Carbohydrate Polymers
The choice of hemostatic technique is a curial concern for surgery and as first-aid treatment in combat. To treat uncontrolled bleeding in complex wound environments, chitosan-based hemostatic sponges have attracted significant attention in recent years because of the excellent biocompatibility, degradability, hemostasis and antibacterial properties of chitosan and their unique sponge-like morphology for high fluid absorption rate and priority aggregation of blood cells/platelets to achieve rapid hemostasis. In this review, we provide a historical perspective on the use of chitosan hemostatic sponges as the new generation of hemostatic materials for uncontrolled bleeding emergencies in complex wounds. We summarize the modification of chitosan, review the current status of preparation protocols of chitosan sponges based on various composite systems, and highlight the recent achievements on the detailed breakdown of the existing chitosan sponges to present the relationship between their composition, physical properties, and hemostatic capacity. Finally, the future opportunities and challenges of chitosan hemostatic sponges are also proposed.
Nanomedicine-based doxorubicin delivery for skin cancer with theranostic potential
2021, Advanced Drug Delivery Systems in the Management of Cancer
The expectancy of life has been increasing in the Western world since long time due to optimal standards of life, good hygienic conditions, and, of course, advancement in modern medicine. The current chapter provides a brief overview of nanotechnology-based treatment approaches for skin cancer. Unique physicochemical characteristics and biomedical advancement for the development of nanocarriers have provided applications in targeting drug delivery, diagnosis, and patient compliance. Doxorubicin (DOX) biodegradable and biocompatible nanocarrier systems have shown enhanced bioavailability, therapeutic index, and thus, reduced treatment costs. For instance, the date of doxorubicin-loaded quaternary ammonium palmitoyl glycol chitosan (DOX-GCPQ) particles serves as translational link for clinical trials assessing anticancer efficacy and diagnostic potential, via DOX optical imaging of formulation after appropriate testing and guidance for further studies, leading to clinical evaluation to determine safety margins of formulation.
Preparation and therapeutic applications of chitosan nanoparticles
2021, Biopolymeric Nanomaterials: Fundamentals and Applications
Chitosan nanoparticles revolutionized the drug delivery methods in the recent years due to their versatile properties and ease of manipulation. Among all the delivery systems, chitosan nanoparticles are most extensively explored for therapeutic and drug delivery applications. Chitosan nanoparticles are easy to prepare by different methods and can be administrated by various routes for better delivery of therapeutic agents. In present chapter, we discuss two main aspects of chitosan nanoparticles. First, chitosan nanoparticles preparation methods will be discussed that include ionotropic gelation method, microemulsion cross-linking method, emulsification solvent diffusion, spray drying, reverse micellar method, and complex coacervation method. The role of variety of cross-linkers stability and cellular interactions of chitosan nanoparticles has been also briefly discussed. In the second part, various delivery routes for delivery of therapeutic molecules via chitosan nanoparticles-based delivery systems will be reviewed. Chitosan nanoparticles are being widely used to enhance the efficiency of drugs or other therapeutic agents such as peptides and proteins by pulmonary, oral, transdermal, and ocular delivery strategies. Chitosan nanoparticles are not limited to therapeutic delivery systems and their applications in various other fields have been also discussed to highlight their immerse potential in nanobiotechnology.
A sodium alginate/feather keratin composite fiber with skin-core structure as the carrier for sustained drug release
2020, International Journal of Biological Macromolecules
Citation Excerpt :
In recent years, the application of SA has drawn more and more attentions [6–10]. Nowadays, its applications in the field of sustained drug release mainly focus on microspheres [11–16]. Making SA the framework with drug dispersed inside, the microspheres can effectively reduce drug release rate.
To alleviate the serious gastrointestinal side reaction of indomethacin (IDM), sodium alginate/feather keratin (SA/FK) fiber with skin-core structure was prepared via wet spinning as the carrier for sustained release of IDM. Fourier translation infrared (FT-IR) spectroscopy was adopted to investigate the reaction mechanism among SA, FK and IDM, and Ultraviolet-visible (UV–Vis) spectroscopy was used to systematically evaluate the sustained release capacity of SA/FK fiber in three simulated fluids. Scanning electron microscope (SEM) was employed to observe the apparent morphology of SA/FK fiber. The results indicate that, release amount of IDM exhibits an increase trend along with time; the release amount of IDM reaches 80% after 12 h in colon fluid and small intestinal fluid, and is less than 20% in digestive fluid. Simultaneously, FK can effectively control the release of IDM, and with the increase of FK content, IDM release time of the carrier fiber extends.
Fundamentals of chitosan for biomedical applications
2020, Handbook of Chitin and Chitosan: Volume 3: Chitin- and Chitosan-based Polymer Materials for Various Applications
There have been various biomaterial developed and used in various biomedical applications. Among all the biomaterials, natural ones are more sophisticated and readily compatible with the human body. This chapter is focused on one of the naturally obtained biomaterials named chitosan. Chitosan possesses many unique properties, such as excellent biodegradability, biocompatibility, nontoxicity, and antimicrobial activity. However, due to its lower solubility in water or other biological fluids, there are some limitations in terms of its application. That is why so many studies have been undertaken to facilitate the given properties. In this chapter, some modification techniques and some frequently used forms of chitosan are discussed and the fundamentals of chitosan as a potent biomaterial in various biomedical fields are reported.
Porous three-dimensional polymer composites for tailored delivery of bioactives and drugs
2019, Materials for Biomedical Engineering: Nanomaterials-based Drug Delivery
Porous three-dimensional polymer networks possess many desirable characteristics for tailored release of bioactives and drugs. Increasingly, natural biopolymers, such as alginate and chitosan, are being used to construct porous networks or encapsulation systems for these applications. This chapter provides an overview of our recent research aimed at developing versatile polymeric composites for therapeutic applications, in particular, three-dimensional interconnected porous biopolymer networks that exhibit unique characteristics in terms of environmental response and intrinsic bioactivity. Innovative scalable processing technologies such as controlled depolymerization, coextrusion, spray-drying, and electrospinning are discussed and are shown to be effective for producing stable polymer composite matrices for bioactives, drugs, and microorganisms including antioxidants, enzyme, and probiotic bacteria. Detailed understanding of the properties of the polymer host (such as chemical composition, molecular weight, spatial arrangement, viscosity, charge, conductivity, interchain interactions, and polyelectrolyte behavior), and the encapsulated bioactives or drugs, allows precise tailoring of composite performance for specific applications.

View all citing articles on Scopus

View full text

Controlled release of indomethacin by chitosan-polyelectrolyte complex: optimization and in vivo/in vitro evaluation

Abstract

Biomaterials

Int. J. Pharm.

J. Pharm. Sci.

J. Pharm. Sci.

J. Pharm. Sci.

Enhancement of dissolution properties of griseofulvin from ground mixtures with chitin or chitosan

Chem. Pharm. Bull.

Enhancement of dissolution properties of prednisolone from ground mixtures with chitin or chitosan

Chem. Pharm. Bull.